Left Atrial Appendage (LAA) Occluders

This channel includes news and new technology innovations about Left Atrial Appendage (LAA) Occluders. These close off the LAA in patients with atrial fibrillation to prevent the formation of stroke-causing clots in atrial fibrillation (AFib or AF) patients. LAA occlusion is often indicated for patients who do not tolerate anticoagulation therpy or have bleeding risks associated with use of that therapy.

LAA occluder, Watchman

Boston Scientific's Watchman LAA occluder device is designed to prevent stroke in patients atrial fibrillation without the need for warfarin therapy.

Feature | November 08, 2013
November 8, 2013 – According to Millennium Research Group (MRG), the anticipated Food and Drug Administration (FDA)...
Videos | November 07, 2013
Herbert Aronow, M.D., MPH, St. Joseph Mercy Hospital, Ann Arbor, and an active member of ACC and SCAI, explains the top...
Lariat Suture Device Left Atrial Appendage Occluder Stroke Risk
News | July 15, 2013
July 15, 2013 — Shore University Medical Center is one of only a handful of hospitals in the country offering the...
FDA US device innovation

The delay in being able to bring new medical device advances to market in the United States, such as transcatheter aortic valves and left atrial appendage occluders, has raised the question of the U.S. leadership role in technology innovation.

Feature | July 03, 2013 | Anita Asgar, M.D., FSCAI
The field of interventional cardiology is one of constant change and innovation. The past 10 years have documented...
Technology | June 28, 2013
June 28, 2013 — Maquet Cardiovascular LLC announced it has acquired LAAx Inc., a privately held company that has...
Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature | May 13, 2013
May 13, 2013 — Boston Scientific reports that the four-year follow-up data from the PROTECT AF clinical trial...
Simbionix ANGIO Mentor Structural Heart Simulator Models
Technology | May 02, 2013
May 2, 2013 — Simbionix USA Corp. released various training modules for the Angio Mentor endovascular simulator. The...
Boston Scientific Watchmen Left Atrial Appendage Closure Atrial Fibrillation
Feature | March 19, 2013
March 19, 2013 — Boston Scientific reports preliminary data in the PREVAIL clinical trial met two out of three co-...
Feature | March 13, 2013
March 13, 2013 — St. Jude Medical Inc. announced the first patient implant in a new pivotal trial evaluating the...
Amplatzer Amulet St. Jude Medical Left Atrial Appendage Occluders
Feature | January 29, 2013
January 29, 2013 — St. Jude Medical Inc. announced European CE mark approval of its Amplatzer Amulet Left Atrial...
News | July 06, 2012
July 6, 2012 — Boston Scientific Corp. has completed enrollment in the PREVAIL confirmatory study, designed to gain U.S...
News | May 14, 2012
May 14, 2012 — Boston Scientific announced results from the ASA Plavix (ASAP) study, which studied the Watchman Left...
Videos | Left Atrial Appendage (LAA) Occluders | April 06, 2012
Siemens' AcuNav V 3-D intracardiac echo (ICE) catheter offers detailed, live 3-D images of the interior of the heart....
Feature | February 01, 2012 | Dave Fornell
Based on my observations and those of the doctors on the Diagnostic & Interventional Cardiology Editorial Advisory...
News | January 25, 2012
January 25, 2012 — Which Medical Device announced the winner of its Device of the Year Award 2011 in the cardiology...